News

Researchers at the University of Cincinnati have developed a new method of delivering radiation therapy to cancer cells – using engineered bacteria.

A newly discovered strategy used by tumors that have spread – and are also more deadly – may help explain why some immunotherapies designed to help the immune system kill cancer are unsuccessful.

Nuclear medicine brain imaging has illustrated the biological changes that occur in chemo brain, which researchers hope will help patients understand the changes in their cognitive status during treatment.

According to research, the breast tumors of Asian, Black and white women have very different cellular, microbial and genomic features that could potentially be used to personalize care or predict disease progression.

Patients with advanced endometrial cancer saw a significant reduction in disease growth with the combination immunotherapy and chemotherapy.

A new drug combination against advanced prostate cancer has shown promise in a new phase 3 trial, increasing 5-year survival rates to 67%.

Detailed mapping of cancer recurrence in the prostate shows that current radiotherapy contouring guidelines may miss lesions and irradiate healthy tissues unnecessarily, in a call for redefinition of guidelines to improve patient outcomes.

The sugars present on the surface of cancer cells are crucial to oncogene-mediated immune evasion, according to a new study.

New research finds that select patients with early-stage non-small cell lung cancer who undergo a less invasive procedure have comparable outcomes to those who receive a lobectomy.

Researchers hope the AI tool will improve diagnosis and treatment of cancerous brain tumors, as well as boost clinical trial enrollment.